HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.

AbstractPURPOSE:
The objective of this study was to evaluate the anti-tumor efficacy and lack of systemic toxicity of paclitaxel when administered in pH-sensitive poly(ethylene oxide) (PEO)-modified poly(beta-amino ester) (PbAE) nanoparticles in mice bearing human ovarian adenocarcinoma (SKOV-3) xenograft.
METHODS:
Paclitaxel-encapsulated PEO-modified PbAE (PEO-PbAE) nanoparticles were prepared by the solvent displacement method. PEO-modified poly(epsilon-caprolactone) (PCL) (PEO-PCL) nanoparticles were used as a non pH-responsive control formulation. Efficacy studies were conducted in SKOV-3 tumor-bearing athymic (Nu/Nu) mice at an equivalent paclitaxel dose of 20 mg/kg with the control and nanoparticle formulations. Safety of the drug when administered in the control and nanoparticle formulation was determined from blood cell counts and changes in body weight of the animals.
RESULTS:
The formulated paclitaxel-containing PEO-PbAE and PEO-PCL nanoparticles had a particle size in the range of 100-200 nm and a surface charge of + 39.0 and - 30.8 mV, respectively. After intravenous administration of paclitaxel in these formulations, the tumor growth was inhibited significantly. Both of the formulated nanoparticles tested have shown improved therapeutic efficacy as compared to the paclitaxel aqueous solution. Additionally, significantly lower toxicity profile of paclitaxel was observed with PEO-modified nanoparticles as compared to the aqueous solution formulation
CONCLUSION:
PEO-modified PbAE nanoparticles are a unique pH-sensitive drug delivery system that elicits enhanced efficacy and safety profile in solid tumor therapy.
AuthorsHarikrishna Devalapally, Dinesh Shenoy, Steven Little, Robert Langer, Mansoor Amiji
JournalCancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 59 Issue 4 Pg. 477-84 (Mar 2007) ISSN: 0344-5704 [Print] Germany
PMID16862429 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Polyesters
  • polycaprolactone
  • Polyethylene Glycols
  • Paclitaxel
Topics
  • Animals
  • Cell Line, Tumor
  • Chemistry, Pharmaceutical
  • Drug Delivery Systems
  • Female
  • Humans
  • Hydrogen-Ion Concentration
  • Mice
  • Nanoparticles
  • Neoplasm Transplantation
  • Ovarian Neoplasms (drug therapy)
  • Paclitaxel (administration & dosage, adverse effects)
  • Polyesters (administration & dosage)
  • Polyethylene Glycols
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: